# BARDA Funds Spectral AI DeepView Program

BARDA is supporting Spectral AI’s DeepView program under a contract with a ceiling of approximately **$150 million**. About **$86.6 million is committed**, including roughly $63.4 million in options, and Spectral AI has a $9.7 million cost share. The company plans up to 30 initial U.S. system deployments by June 2027. The article title also reports completion of a Phase I SBIR contract with the U.S. Air Force through AFWERX, but the article body provides no supporting contract details; it identifies no open solicitation or subcontracting opportunity.

- The DeepView program’s committed funding and planned deployments are relevant to health-technology contractors assessing federal medical-technology development and deployment activity.
- Companies seeking to participate should note that the source does not identify an active procurement, subcontracting channel, or procurement contact; it provides no basis for treating the reported program as an open bid opportunity.
- The Air Force/AFWERX SBIR completion is a separate, limited report. The source provides no award value, contract number, follow-on phase, or solicitation details.

**Jurisdictions:** federal
**Industries:** Healthcare, Defense & Military
**Topics:** Artificial Intelligence, Grants & Funding
**Published:** October 29, 2026

### Government Entities
- Biomedical Advanced Research and Development Authority (BARDA)
- U.S. Air Force (USAF)
- AFWERX (AFWERX)

### Vendors
- Spectral AI (BARDA contract recipient; DeepView program awardee)

### Sources
- [$SPAI Spectral AI news: Completed Phase I of its SBIR contract with the U.S. Air Force (AFWERX).

$SPAI trades at $3.34 (-1.5% today, Thu Oct 29), below the 50-day SMA ($4.29) and below the 200-day ($4.50). Daily RSI 37.

SPAI hub: https://t.co/rialgd2KJ6
Interactive chart with b](https://x.com/merlin_trader/status/2115830844241715680) - twitter-defense